 LATHAM, N.Y.--BUSINESS WIRE--AngioDynamics, Inc. NASDAQ: ANGO, a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the first quarter of fiscal year 2022, which ended August 31, 2021. We had a solid first quarter, and our team continues to deliver strong revenue performance and invest in our growth drivers while advancing our ongoing transformation, commented Jim Clemmer, 